News from neurostar advanced therapy A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 08, 2019, 07:30 ET NeuroStar® Patient Outcomes Registry Has Now Surpassed 3,000 Evaluable Patients, Making It The World's Largest in Major Depressive Disorder

Neuronetics, Inc. (NASDAQ: STIM) – Neuronetics, Inc., the developer of NeuroStar® Advanced Therapy, announced today that its depression outcomes...

Feb 21, 2019, 08:00 ET NeuroStar® Advanced Therapy to Host Industry Best Practices Symposia at Clinical TMS Society Annual Meeting

Neuronetics, Inc. (NASDAQ:STIM) — NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), will present...

Nov 13, 2018, 08:00 ET NeuroStar® Advanced Therapy and Transformations TMS Expanding Partnership to Increase Patient Access to Depression Treatment

NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), announced an expanded partnership with GRW Health,...

Oct 11, 2018, 08:30 ET NeuroStar® Advanced Therapy Hits 2 Million Treatments During National Depression Awareness Month

NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), announced it has reached its two million treatment...
NeuroStar® Advanced Therapy Reaches Monumental Milestone of 1.7 Million Treatments in the US

May 05, 2018, 08:00 ET NeuroStar® Advanced Therapy Reaches Monumental Milestone of 1.7 Million Treatments in the US

NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), announced today that more than 1.7 million treatments ...

Oct 16, 2017, 10:00 ET Neuronetics, Inc. Partners with Teijin Pharma Limited, a Leading Healthcare Company in Japan, to Distribute NeuroStar Advanced Therapy

Neuronetics, Inc., a privately held medical device company widely recognized as the market-leader in transcranial magnetic stimulation (TMS),...

Oct 11, 2017, 14:12 ET NeuroStar® Advanced Therapy Approved as a Life-Changing Depression Treatment to Help Conquer Depression in Japan

Neuronetics, Inc., a privately held medical device company widely recognized as the market-leader in transcranial magnetic stimulation (TMS),...

Jun 06, 2017, 09:15 ET Neuronetics, Inc. Raises $15 Million in Series G Equity Financing, Led by Ascension Ventures

Neuronetics, Inc., a privately held medical device company widely recognized as the market-leader in transcranial magnetic stimulation (TMS) therapy, ...

May 22, 2017, 09:04 ET NeuroStar® Advanced Therapy Depression Outcomes Registry Surpasses 500 Patient Milestone

NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), today announced its depression outcomes registry has...

Apr 12, 2017, 09:00 ET Roadblocks to Treatment for People Suffering from Depression Continue to be Lifted with Next Generation NeuroStar® Advanced Therapy

NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS) therapy, is now the only FDA-cleared TMS treatment in...

Nov 21, 2016, 09:00 ET NeuroStar® Launches Largest Depression Outcomes Registry to Date

NeuroStar announced today the launch of the largest depression outcomes registry ever in patients treated with its TMS (transcranial magnetic...